KG
Kathleen Goin (Chief Operating Officer) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Palvella Therapeutics, Inc. (PVLA). The largest single filing was $655K of PVLA (4,302 sh across 3 lots, as filed), executed Sep 16. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
12
0 buys · 12 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.0M
shares × price, as filed
Last traded
Oct 21
Filed Oct 23
Median ADV $37.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
12 filings
Sector per market data · by filing · past 12 months
Most traded names
PVLARecent filings
PVLASALE
Palvella Therapeutics, Inc.
View filing →
$342K4,302 sh across 2 lots
Exec Feb 18
Filed Feb 20 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $367K
3,749 sh × $97.94
Exec Jan 21
Filed Jan 23 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $415K
4,302 sh × $96.47
Exec Dec 17 2025
Filed Dec 19 2025 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $371K
4,302 sh across 2 lots
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET